Condition: Mitral Valve Insufficiency · Sponsor: Hangzhou Valgen Medtech Co., Ltd
To confirm the effectiveness and safety of the DragonFly Transcatheter Mitral Valve Repair System for the treatment of symptomatic moderate-to-severe (3+) or severe (4+) degenerative mitral regurgitation in high surgical risk subjects and symptomatic moderate-to- severe (3+) or severe (4+) functional mitral regurgitation subjects who remained clinically symptomatic after adequate treatment.
This description comes directly from the study's public registry record.
Shuangjie Li · +8617756106609 · shuangjie.li@valgenmed.com
Always discuss trial participation with your own doctor first.
| Universitatsklinikum Bonn Medizinische Klinik und Poliklinik | Bonn, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05927441